Mark A Gardner is SVP of Molecular Gen & Oncol of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 4,673 shares of DGX, which is worth approximately $640,621. The most recent transaction as insider was on Sep 24, 2024, when has been sold 120 shares (Common Stock) at a price of $155.7 per share, resulting in proceeds of $18,684. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.67K
2.5% 3M change
66.6% 12M change
Total Value Held $640,621

MARK A GARDNER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 24 2024
SELL
Payment of exercise price or tax liability
$18,684 $155.7 p/Share
120 Reduced 2.5%
4,673 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$33,106 $126.36 p/Share
262 Reduced 5.18%
4,793 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
2,250 Added 30.8%
5,055 Common Stock
Sep 25 2023
SELL
Payment of exercise price or tax liability
$14,641 $126.22 p/Share
116 Reduced 3.97%
2,805 Common Stock
Feb 23 2023
BUY
Grant, award, or other acquisition
-
1,919 Added 39.65%
2,921 Common Stock
MAG

Mark A Gardner

SVP of Molecular Gen & Oncol
Secaucus, NJ

Track Institutional and Insider Activities on DGX

Follow QUEST DIAGNOSTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX